California State Teachers Retirement System (CalSTRS)
HBIO icon

California State Teachers Retirement System (CalSTRS)’s Harvard Bioscience HBIO Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-295
Closed -$1.67K – 3049
2025
Q1 		$1.67K Hold
295
– – ﹤0.01% 3026
2024
Q4 		$6.23K Hold
295
– – ﹤0.01% 2965
2024
Q3 		$7.94K Hold
295
– – ﹤0.01% 2944
2024
Q2 		$8.42K Sell
295
-113
-28% -$3.96K ﹤0.01% 2952
2024
Q1 		$17.3K Sell
408
-259
-39% -$11.6K ﹤0.01% 2779
2023
Q4 		$35.7K Sell
667
-217
-25% -$9.8K ﹤0.01% 2723
2023
Q3 		$38K Sell
884
-417
-32% -$19.2K ﹤0.01% 2803
2023
Q2 		$71.4K Buy
+1,301
New +$71.4K ﹤0.01% 2779
2022
Q2 		– Sell
-1,675
Closed -$104K – 3210
2022
Q1 		$104K Sell
1,675
-510
-23% -$30.2K ﹤0.01% 2857
2021
Q4 		$154K Hold
2,185
– – ﹤0.01% 2875
2021
Q3 		$153K Sell
2,185
-3,121
-59% -$248K ﹤0.01% 2848
2021
Q2 		$442K Sell
5,306
-382
-7% -$27K ﹤0.01% 2707
2021
Q1 		$311K Hold
5,688
– – ﹤0.01% 2717
2020
Q4 		$244K Hold
5,688
– – ﹤0.01% 2753
2020
Q3 		$171K Hold
5,688
– – ﹤0.01% 2795
2020
Q2 		$176K Buy
+5,688
New +$153K ﹤0.01% 2774
2019
Q2 		– Sell
-5,647
Closed -$243K – 3054
2019
Q1 		$243K Hold
5,647
– – ﹤0.01% 2690
2018
Q4 		$180K Buy
5,647
+270
+5% +$10.6K ﹤0.01% 2794
2018
Q3 		$282K Hold
5,377
– – ﹤0.01% 2734
2018
Q2 		$288K Buy
+5,377
New +$275K ﹤0.01% 2742
2016
Q2 		– Sell
-7,265
Closed -$219K – 3017
2016
Q1 		$219K Buy
7,265
+1,063
+17% +$30.1K ﹤0.01% 2777
2015
Q4 		$215K Buy
6,202
+112
+2% +$3.83K ﹤0.01% 2829
2015
Q3 		$230K Sell
6,090
-20
-0.3% -$931 ﹤0.01% 2837
2015
Q2 		$348K Buy
+6,110
New +$348K ﹤0.01% 2788
2014
Q2 		– Sell
-4,885
Closed -$232K – 3039
2014
Q1 		$232K Buy
4,885
+290
+6% +$13.2K ﹤0.01% 2828
2013
Q4 		$216K Sell
4,595
-1,466
-24% -$64K ﹤0.01% 2863
2013
Q3 		$242K Buy
6,061
+198
+3% +$7.79K ﹤0.01% 2808
2013
Q2 		$210K Buy
+5,863
New +$224K ﹤0.01% 2817

Other funds holding HBIO

AE
AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return
HP
Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS)'s HBIO Position: Q2 2025 in Review

California State Teachers Retirement System (CalSTRS) sold out of Harvard Bioscience (HBIO) in Q2 2025, closing a stake of 295 shares — an estimated $1.67K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in HBIO in Q2 2013 and held it in 28 quarters. The position peaked at $442K in Q2 2021. 68 funds tracked by Wall St. Rank hold HBIO as of Q2 2025.

  • California State Teachers Retirement System (CalSTRS) reported no remaining Harvard Bioscience position as of Q2 2025 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 295 Harvard Bioscience shares in Q2 2025, an estimated $1.67K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Harvard Bioscience in Q2 2013 and held it in 28 quarters.
  • California State Teachers Retirement System (CalSTRS)'s Harvard Bioscience position peaked at $442K in Q2 2021.
  • 68 funds tracked by Wall St. Rank held Harvard Bioscience as of Q2 2025.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2025, filed 14 Aug 2025.